HYBRID EVENT: You can participate in person at Orlando, USA or Virtually from your home or work.
Vaccines Business Development
Collaboration plays an important role in the success of Vaccines Business Development.
Vaccines Business development comprises a many of works and processes generally targeting at developing and implementing growth opportunities within and between organizations. This is a subsection in the field of business, commerce and organizational theory. The development of vaccine programs face number of challenges that sets them separate from other types development programs of healthcare products.
Companies place a great importance on associating with other companies, institutions and organizations because they know that many great ideas come from outside our companies.
Committee Members
Chil-Yong Kang
The University of Western Ontario, Canada
Birger Trollfors
Sahlgrenska University Hospital, Sweden
Giuseppe Bardi
Italian institute of technology, Italy
Kevin Galalae
Center of Global Consciousness, CanadaSubmit your abstract Today
Title : Vaccine-adjuvant nanotechnologies: Tailoring immune-interaction properties of nano particles
Giuseppe Bardi, Istituto Italiano di Tecnologia, Italy
Title : BCG an old vaccine, but still it is effective
Birger Trollfors, Birger Trollfors, Sahlgrenska University Hospital, Gothenburg, Sweden
Title : Creation of Universal Viral Vectors for Prophylactic and Therapeutic Viral and Bacterial Diseases
Chil-Yong Kang, University of Western Ontario in Canada.
Title : The pyrexia temperature never damages the cells of the brain or harm the body.
Yacob Mathai, Marma Health Centre,India
Title : Steps to Modern Conversions in use of Autogenous bacterin of Vibrio algenolyticus induce Cross-protection against Listonella anguillarum in sea bass Dicentrarchus labrax L and vice versa
Riad Hassan Khalil, Alexandria University, Egypt